Global (United States, European Union and China) Opioids Agonist Drugs Market Research Report 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Codeine
1.3.3 Fentanyl
1.3.4 Meperidine
1.3.5 Methadone
1.3.6 Morphine
1.3.7 Hydrocodone
1.4 Market Segment by Application
1.4.1 Global Opioids Agonist Drugs Market Share by Application (2019-2025)
1.4.2 Pain Management
1.4.3 Cough Treatment
1.4.4 Diarrhea Treatment
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioids Agonist Drugs Market Size
2.1.1 Global Opioids Agonist Drugs Revenue 2014-2025
2.1.2 Global Opioids Agonist Drugs Sales 2014-2025
2.2 Opioids Agonist Drugs Growth Rate by Regions
2.2.1 Global Opioids Agonist Drugs Sales by Regions 2014-2019
2.2.2 Global Opioids Agonist Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Opioids Agonist Drugs Sales by Manufacturers
3.1.1 Opioids Agonist Drugs Sales by Manufacturers 2014-2019
3.1.2 Opioids Agonist Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Opioids Agonist Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Opioids Agonist Drugs Price by Manufacturers
3.4 Key Manufacturers Opioids Agonist Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Opioids Agonist Drugs Market
3.6 Key Manufacturers Opioids Agonist Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Codeine Sales and Revenue (2014-2019)
4.1.2 Fentanyl Sales and Revenue (2014-2019)
4.1.3 Meperidine Sales and Revenue (2014-2019)
4.1.4 Methadone Sales and Revenue (2014-2019)
4.1.5 Morphine Sales and Revenue (2014-2019)
4.1.6 Hydrocodone Sales and Revenue (2014-2019)
4.2 Global Opioids Agonist Drugs Sales Market Share by Type
4.3 Global Opioids Agonist Drugs Revenue Market Share by Type
4.4 Opioids Agonist Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Opioids Agonist Drugs Sales by Application
6 United States
6.1 United States Opioids Agonist Drugs Breakdown Data by Company
6.2 United States Opioids Agonist Drugs Breakdown Data by Type
6.3 United States Opioids Agonist Drugs Breakdown Data by Application
7 European Union
7.1 European Union Opioids Agonist Drugs Breakdown Data by Company
7.2 European Union Opioids Agonist Drugs Breakdown Data by Type
7.3 European Union Opioids Agonist Drugs Breakdown Data by Application
8 China
8.1 China Opioids Agonist Drugs Breakdown Data by Company
8.2 China Opioids Agonist Drugs Breakdown Data by Type
8.3 China Opioids Agonist Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Opioids Agonist Drugs Breakdown Data by Company
9.2 Rest of World Opioids Agonist Drugs Breakdown Data by Type
9.3 Rest of World Opioids Agonist Drugs Breakdown Data by Application
9.4 Rest of World Opioids Agonist Drugs Breakdown Data by Countries
9.4.1 Rest of World Opioids Agonist Drugs Sales by Countries
9.4.2 Rest of World Opioids Agonist Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Purdue Pharma
10.1.1 Purdue Pharma Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.1.4 Opioids Agonist Drugs Product Introduction
10.1.5 Purdue Pharma Recent Development
10.2 Titan pharmaceuticals
10.2.1 Titan pharmaceuticals Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.2.4 Opioids Agonist Drugs Product Introduction
10.2.5 Titan pharmaceuticals Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.3.4 Opioids Agonist Drugs Product Introduction
10.3.5 Boehringer Ingelheim Recent Development
10.4 Janssen Pharmaceuticals, Inc
10.4.1 Janssen Pharmaceuticals, Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.4.4 Opioids Agonist Drugs Product Introduction
10.4.5 Janssen Pharmaceuticals, Inc Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.5.4 Opioids Agonist Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 Sun Pharmaceuticals
10.6.1 Sun Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.6.4 Opioids Agonist Drugs Product Introduction
10.6.5 Sun Pharmaceuticals Recent Development
10.7 Mallinckrodt Pharmaceuticals
10.7.1 Mallinckrodt Pharmaceuticals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.7.4 Opioids Agonist Drugs Product Introduction
10.7.5 Mallinckrodt Pharmaceuticals Recent Development
10.8 Egalet Corporation
10.8.1 Egalet Corporation Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.8.4 Opioids Agonist Drugs Product Introduction
10.8.5 Egalet Corporation Recent Development
10.9 Endo Pharmaceuticals Inc.
10.9.1 Endo Pharmaceuticals Inc. Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.9.4 Opioids Agonist Drugs Product Introduction
10.9.5 Endo Pharmaceuticals Inc. Recent Development
10.10 Allergan, Plc
10.10.1 Allergan, Plc Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
10.10.4 Opioids Agonist Drugs Product Introduction
10.10.5 Allergan, Plc Recent Development
10.11 Pfizer Inc
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Opioids Agonist Drugs Sales Channels
11.2.2 Opioids Agonist Drugs Distributors
11.3 Opioids Agonist Drugs Customers
12 Market Forecast
12.1 Global Opioids Agonist Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Opioids Agonist Drugs Sales Forecast by Type
12.3 Global Opioids Agonist Drugs Sales Forecast by Application
12.4 Opioids Agonist Drugs Forecast by Regions
12.4.1 Global Opioids Agonist Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Opioids Agonist Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and FiguresFigure Opioids Agonist Drugs Product Picture
Table Opioids Agonist Drugs Key Market Segments
Table Major Manufacturers Opioids Agonist Drugs Covered in This Report
Table Global Opioids Agonist Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Opioids Agonist Drugs Sales Market Shar by Type 2014-2025
Figure Codeine Figures
Table Major Manufacturers of Codeine
Figure Fentanyl Figures
Table Major Manufacturers of Fentanyl
Figure Meperidine Figures
Table Major Manufacturers of Meperidine
Figure Methadone Figures
Table Major Manufacturers of Methadone
Figure Morphine Figures
Table Major Manufacturers of Morphine
Figure Hydrocodone Figures
Table Major Manufacturers of Hydrocodone
Table Global Opioids Agonist Drugs Market Share by Application 2019-2025 (K Units)
Figure Pain Management Use Case
Figure Cough Treatment Use Case
Figure Diarrhea Treatment Use Case
Figure Opioids Agonist Drugs Report Years Considered
Figure Global Opioids Agonist Drugs Market Size 2014-2025 (Million US$)
Figure Global Opioids Agonist Drugs Sales 2014-2019 (K Units)
Table Global Opioids Agonist Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Opioids Agonist Drugs Sales by Regions 2014-2019 (K Units)
Table Global Opioids Agonist Drugs Sales Market Share by Regions 2014-2019
Figure Global Opioids Agonist Drugs Sales Market Share by Regions 2014-2019
Figure Global Opioids Agonist Drugs Sales Market Share by Regions in 2019
Table Global Opioids Agonist Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Opioids Agonist Drugs Revenue Market Share by Regions 2014-2019
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions 2014-2019
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Opioids Agonist Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Opioids Agonist Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Opioids Agonist Drugs Sales Share by Manufacturers in 2019
Table Opioids Agonist Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
Figure Opioids Agonist Drugs Value Share by Manufacturers in 2019
Table Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioids Agonist Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Opioids Agonist Drugs Plants/Factories Distribution
Table Key Manufacturers Opioids Agonist Drugs Area Served
Table Date of Key Manufacturers Enter into Opioids Agonist Drugs Market
Table Key Manufacturers Opioids Agonist Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Codeine Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Fentanyl Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Meperidine Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Methadone Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Morphine Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Hydrocodone Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Opioids Agonist Drugs Sales by Type (2014-2019) (K Units)
Table Global Opioids Agonist Drugs Sales Share by Type (2014-2019)
Figure Global Opioids Agonist Drugs Sales Market Share by Type (2014-2019)
Figure Global Opioids Agonist Drugs Sales Market Share by Type in 2018
Table Global Opioids Agonist Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Opioids Agonist Drugs Revenue Share by Type (2014-2019)
Figure Global Opioids Agonist Drugs Revenue Market Share by Type (2014-2019)
Figure Global Opioids Agonist Drugs Revenue Market Share by Type in 2018
Table Opioids Agonist Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Opioids Agonist Drugs Sales by Application (2014-2019) (K Units)
Table Global Opioids Agonist Drugs Sales Share by Application (2014-2019)
Figure Global Sales Opioids Agonist Drugs Market Share by Application (2014-2019)
Figure Global Sales Opioids Agonist Drugs Market Share by Application (2014-2019)
Figure United States Opioids Agonist Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Opioids Agonist Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Opioids Agonist Drugs Sales by Company (2014-2019) (K Units)
Table United States Opioids Agonist Drugs Sales Market Share by Company (2014-2019)
Figure United States Opioids Agonist Drugs Sales Market Share by Company in 2019
Table United States Opioids Agonist Drugs Sales by Type (2014-2019) (K Units)
Table United States Opioids Agonist Drugs Sales Market Share by Type (2014-2019)
Figure United States Opioids Agonist Drugs Market Share by Type in 2019
Table United States Opioids Agonist Drugs Sales by Application (2014-2019) (K Units)
Table United States Opioids Agonist Drugs Sales Market Share by Application (2014-2019)
Figure United States Opioids Agonist Drugs Market Share by Application in 2019
Figure European Union Opioids Agonist Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Opioids Agonist Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Opioids Agonist Drugs Sales by Company (2014-2019) (K Units)
Table European Union Opioids Agonist Drugs Sales Market Share by Company (2014-2019)
Figure European Union Opioids Agonist Drugs Sales Market Share by Company in 2019
Table European Union Opioids Agonist Drugs Sales by Type (2014-2019) (K Units)
Table European Union Opioids Agonist Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Opioids Agonist Drugs Market Share by Type
Table European Union Opioids Agonist Drugs Sales by Application (2014-2019) (K Units)
Table European Union Opioids Agonist Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Opioids Agonist Drugs Market Share by Application
Figure China Opioids Agonist Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Opioids Agonist Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Opioids Agonist Drugs Sales by Company (2014-2019) (K Units)
Table China Opioids Agonist Drugs Sales Market Share by Company (2014-2019)
Figure China Opioids Agonist Drugs Sales Market Share by Company in 2019
Table China Opioids Agonist Drugs Sales by Type (2014-2019) (K Units)
Table China Opioids Agonist Drugs Sales Market Share by Type (2014-2019)
Figure China Opioids Agonist Drugs Market Share by Type in 2019
Table China Opioids Agonist Drugs Sales by Application (2014-2019) (K Units)
Table China Opioids Agonist Drugs Sales Market Share by Application (2014-2019)
Figure China Opioids Agonist Drugs Market Share by Application in 2019
Figure Rest of World Opioids Agonist Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Opioids Agonist Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Opioids Agonist Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Opioids Agonist Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Opioids Agonist Drugs Sales Market Share by Company in 2019
Table Rest of World Opioids Agonist Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Opioids Agonist Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Opioids Agonist Drugs Market Share by Type in 2019
Table Rest of World Opioids Agonist Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Opioids Agonist Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Opioids Agonist Drugs Market Share by Application in 2019
Table Rest of World Opioids Agonist Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Opioids Agonist Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Opioids Agonist Drugs Sales Market Share by Countries in 2019
Table Rest of World Opioids Agonist Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Opioids Agonist Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Opioids Agonist Drugs Revenue Market Share by Countries in 2019
Figure Japan Opioids Agonist Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Opioids Agonist Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Opioids Agonist Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Opioids Agonist Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Opioids Agonist Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Opioids Agonist Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Opioids Agonist Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Opioids Agonist Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Purdue Pharma Company Details
Table Purdue Pharma Description and Business Overview
Table Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Purdue Pharma Opioids Agonist Drugs Sales Market Share in Global Market
Table Purdue Pharma Recent Development
Table Titan pharmaceuticals Company Details
Table Titan pharmaceuticals Description and Business Overview
Table Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Titan pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Titan pharmaceuticals Opioids Agonist Drugs Sales Market Share in Global Market
Table Titan pharmaceuticals Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Opioids Agonist Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Janssen Pharmaceuticals, Inc Company Details
Table Janssen Pharmaceuticals, Inc Description and Business Overview
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Market Share in Global Market
Table Janssen Pharmaceuticals, Inc Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Sanofi Opioids Agonist Drugs Sales Market Share in Global Market
Table Sanofi Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Description and Business Overview
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales Market Share in Global Market
Table Sun Pharmaceuticals Recent Development
Table Mallinckrodt Pharmaceuticals Company Details
Table Mallinckrodt Pharmaceuticals Description and Business Overview
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Market Share in Global Market
Table Mallinckrodt Pharmaceuticals Recent Development
Table Egalet Corporation Company Details
Table Egalet Corporation Description and Business Overview
Table Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Egalet Corporation Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Egalet Corporation Opioids Agonist Drugs Sales Market Share in Global Market
Table Egalet Corporation Recent Development
Table Endo Pharmaceuticals Inc. Company Details
Table Endo Pharmaceuticals Inc. Description and Business Overview
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Market Share in Global Market
Table Endo Pharmaceuticals Inc. Recent Development
Table Allergan, Plc Company Details
Table Allergan, Plc Description and Business Overview
Table Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan, Plc Opioids Agonist Drugs Sales Growth Rate (2014-2019)
Table Allergan, Plc Opioids Agonist Drugs Sales Market Share in Global Market
Table Allergan, Plc Recent Development
Table Pfizer Inc Company Details
Figure Opioids Agonist Drugs Value Chain
Table Opioids Agonist Drugs Distributors List
Table Opioids Agonist Drugs Customers List
Table Global Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Opioids Agonist Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Opioids Agonist Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Opioids Agonist Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Opioids Agonist Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Opioids Agonist Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure China Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure India Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Opioids Agonist Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Opioids Agonist Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources